In a recent government meeting, concerns were raised about the impact of international policies on U.S. scientific research, particularly regarding the importation of materials from Cambodia. Stakeholders, including scientific researchers and their suppliers in the United States, have faced significant disadvantages due to these policies. While the U.S. has implemented restrictions, countries like Canada, Japan, and Korea continue to import from Cambodia under valid CITES permits, allowing them to maintain their research activities.

The meeting highlighted that China, despite its own export ban, is advancing its primate bioscience research without interruption. This situation poses a challenge for U.S. health care organizations and the broader American public, who rely on scientific advancements for cures and vaccines. The implications of these international dynamics were underscored by the participants, emphasizing the need for a reevaluation of U.S. policies to ensure that American stakeholders are not left behind in the global research landscape.

Dr. Clements, who was invited to provide insights during the hearing, expressed gratitude for the opportunity to contribute to the discussion, indicating a collaborative effort to address these pressing issues.